These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8929249)

  • 1. Commentary on the publication of the study by Plavsić et al., "Bioequivalence of two oral cyclosporine preparations" in Arzneim.-Forsch./Drug Res. 45 (II), No.8, p. 914-917 (1995).
    Holt DW; Johnston A
    Arzneimittelforschung; 1995 Nov; 45(11):1242-4. PubMed ID: 8929249
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of two cyclosporine formulations in healthy volunteers: bioequivalence of the new Sang-35 formulation and Neoral.
    Schroeder TJ; Cho MJ; Pollack GM; Floc'h R; Moran HB; Levy R; Moore LW; Pouletty P
    J Clin Pharmacol; 1998 Sep; 38(9):807-14. PubMed ID: 9753208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.
    Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R
    Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability versus bioequivalence: the cyclosporine model.
    Masri MA
    Exp Clin Transplant; 2003 Dec; 1(2):119-24. PubMed ID: 15859918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioequivalence and therapeutic exchange of pharmaceutical specialties: application to cyclosporin in renal transplantation].
    Pérez Ruixo JJ; Porta B; Jiménez Torres NV
    Nefrologia; 2003; 23(1):71-80. PubMed ID: 12708379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of absorption characteristics of microemulsion cyclosporine products over the last 2 years in Indian subjects.
    Singh S; Sharma DR
    J Indian Med Assoc; 1999 Mar; 97(3):114-7. PubMed ID: 10652912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic cyclosporine: a word of caution.
    Ponticelli C
    J Nephrol; 2004; 17 Suppl 8():S20-4. PubMed ID: 15599881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two microemulsion of cyclosporine A in healthy volunteers.
    Tanasescu C; Serbanescu A; Spadaro A; Jen LH; Oliani C
    Eur Rev Med Pharmacol Sci; 1999; 3(1):5-9. PubMed ID: 10710823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients.
    Hibberd AD; Trevillian PR; Roger SD; Wlodarczyk JH; Stein AM; Bohringer EG; Milson-Hawke SM
    Transplantation; 2006 Mar; 81(5):711-7. PubMed ID: 16534473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New cyclosporine microemulsion randomized, cross-over bioequivalence steady-state study in renal transplanted patients.
    Sinescu I; Lopes HV; Foschi D; Jen LH; Oliani C
    Eur Rev Med Pharmacol Sci; 1999; 3(1):11-8. PubMed ID: 10710824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability of limited sampling strategy to cyclosporine A oral formulation.
    Singh S; Sharma DR; Singh A
    Indian J Exp Biol; 2000 Aug; 38(8):824-6. PubMed ID: 12557917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal time for therapeutic drug monitoring of cyclosporine microemulsion in patients with psoriasis.
    Umezawa Y; Ozawa A
    Int J Dermatol; 2007 Jul; 46(7):763-6. PubMed ID: 17614813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conversion from Consupren sol. to Consupren S capsules in kidney transplant patients].
    Matl I; Vítko S; Bubenícek P; Horcicková M; Lácha J; Lánská V; Marecková O; Nosková L; Petrásek R; Reneltová I; Táborský P
    Vnitr Lek; 1999 Mar; 45(3):167-9. PubMed ID: 15641241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
    Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K
    Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations concerning the introduction of generic formulations of cyclosporine.
    Kahan BD
    Transplant Proc; 1999 May; 31(3):1634; discussion 1675-84. PubMed ID: 10331030
    [No Abstract]   [Full Text] [Related]  

  • 17. ["Critical dose" drugs. Aut-idem could cause problems here].
    MMW Fortschr Med; 2002 Jan; 144(3-4):63. PubMed ID: 11862801
    [No Abstract]   [Full Text] [Related]  

  • 18. Preprandial vs. postprandial pharmacokinetics of cyclosporine in patients with psoriasis.
    Umezawa Y; Mabuchi T; Ozawa A
    Int J Dermatol; 2007 Aug; 46(8):880-2. PubMed ID: 17651179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence of Neoplanta capsule to Sandimmune Neoral, microemulsion formulations of cyclosporin A in human subjects.
    Lee YJ; Chung SJ; Shim CK
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):210-5. PubMed ID: 9587047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.